SAB Biotherapeutics, Inc. (SABS): auditor change — SAB Biotherapeutics appoints EisnerAmper as new auditor after MHM resignation

SAB Biotherapeutics, Inc.

EisnerAmper LLP engaged as independent auditor for FY 2023 and Q3 2023 review, effective Aug 18, 2023.
Audit Committee and Board unanimously approved the engagement; no prior consultations with EisnerAmper occurred.
MHM resigned as auditor on Aug 21, 2023, as previously reported on July 31, 2023.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

SAB Biotherapeutics, Inc. engaged EisnerAmper LLP as its auditor.

Action: engagement
Auditor: EisnerAmper LLP

Exact text from the filing

On August 18, 2023, SAB Biotherapeutics, Inc. (the "Company") engaged EisnerAmper LLP ("EisnerAmper") as the Company's independent public accounting firm

View on SEC.gov

Browse all auditor changes →

SAB Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-043561

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.